A novel New Delhi metallo-β-lactamase variant, NDM-14, isolated in a Chinese hospital possesses increased enzymatic activity against carbapenems

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 4, 2015, Pages 2450-2453

  Zou, Dayang ^a   Huang, Yong ^a   Zhao, Xiangna ^a   Liu, Wei ^a   Dong, Derong ^a   Li, Huan ^a   Wang, Xuesong ^a   Huang, Simo ^a   Wei, Xiao ^a   Yan, Xiabei ^a   Yang, Zhan ^a   Tong, Yigang ^a   Huang, Liuyu ^a   Yuan, Jing ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; CARBAPENEM DERIVATIVE; CARBAPENEMASE; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; ENZYME VARIANT; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; METALLO BETA LACTAMASE VARIANT; TIGECYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA LACTAMASE; BETA-LACTAMASE NDM-1; THIENAMYCIN DERIVATIVE;

ACINETOBACTER LWOFFII; AMINO ACID SUBSTITUTION; ARTICLE; BACTERIUM ISOLATE; CHINA; CHINESE; ENZYME ACTIVITY; HOSPITAL; HUMAN; INTENSIVE CARE UNIT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; ACINETOBACTER; ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; CROSS INFECTION; DRUG EFFECTS; GENETICS; KINETICS; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; PLASMID;

ACINETOBACTER; ACINETOBACTER INFECTIONS; AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARBAPENEMS; CHINA; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; HUMANS; IMIPENEM; INTENSIVE CARE UNITS; KINETICS; MOLECULAR SEQUENCE DATA; PLASMIDS; THIENAMYCINS;

EID: 84949117075     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05168-14     Document Type: Article

References (20)

1. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S, Krishnan P, Kumar AV, Maharjan S, Mushtaq S, Noorie T, Paterson DL, Pearson A, Perry C, Pike R, Rao B, Ray U, Sarma JB, Sharma M, Sheridan E, Thirunarayan MA, Turton J, Upadhyay S, Warner M, Welfare W, Livermore DM, Woodford N. 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: A molecular, biological, and epidemiological study. Lancet Infect Dis 10:597-602. http://dx.doi.org/10.1016/S1473-3099(10)70143-2.
2. Berrazeg M, Diene S, Medjahed L, Parola P, Drissi M, Raoult D, Rolain J. 2014. New Delhi metallo-beta-lactamase around the world: An eReview using Google Maps. Euro Surveill 19:20809. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20809.
3. Fu Y, Du X, Ji J, Chen Y, Jiang Y, Yu Y. 2012. Epidemiological characteristics and genetic structure of blaNDM-1 in non-baumannii Acinetobacter spp. in China. J Antimicrob Chemother 67:2114-2122. http://dx.doi.org/10.1093/jac/dks192.
4. Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing: 24th informational supplement M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Denisuik AJ, Lagacé-Wiens PR, Pitout JD, Mulvey MR, Simner PJ, Tailor F, Karlowsky JA, Hoban DJ, Adam HJ, Zhanel GG. 2013. Molecular epidemiology of extended-spectrum βlactamase-, AmpC βlactamase- And carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11. J Antimicrob Chemother 68:i57-i65. http://dx.doi.org/10.1093/jac/dkt027.
6. Akers KS, Chaney C, Barsoumian A, Beckius M, Zera W, Yu X, Guymon C, Keen EF, Robinson BJ, Mende K. 2010. Aminoglycoside resistance and susceptibility testing errors in Acinetobacter baumannii-calcoaceticus complex. J Clin Microbiol 48:1132-1138. http://dx.doi.org/10.1128/JCM.02006-09.
7. Walsh TR, Weeks J, Livermore DM, Toleman MA. 2011. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: An environmental point prevalence study. Lancet Infect Dis 11:355-362. http://dx.doi.org/10.1016/S1473-3099(11)70059-7.
8. Borgia S, Lastovetska O, Richardson D, Eshaghi A, Xiong J, Chung C, Baqi M, McGeer A, Ricci G, Sawicki R, Pantelidis R, Low DE, Patel SN, Melano RG. 2012. Outbreak of carbapenem-resistant Enterobacteriaceae containing blaNDM-1, Ontario, Canada. Clin Infect Dis 55:e109-e117. http://dx.doi.org/10.1093/cid/cis737.
9. Merriman B, Torrent I, Rothberg JM, Team D. 2012. Progress in Ion Torrent semiconductor chip based sequencing. Electrophoresis 33:3397- 3417. http://dx.doi.org/10.1002/elps.201200424.
10. Göttig S, Hamprecht AG, Christ S, Kempf VA, Wichelhaus TA. 2013. Detection of NDM-7 in Germany, a new variant of the New Delhi metallobeta- lactamase with increased carbapenemase activity. J Antimicrob Chemother 68:1737-1740. http://dx.doi.org/10.1093/jac/dkt088.
11. Tada T, Miyoshi-Akiyama T, Shimada K, Kirikae T. 2014. Biochemical analysis of metallo-beta-lactamase NDM-3 from a multidrug-resistant Escherichia coli strain isolated in Japan. Antimicrob Agents Chemother 58:3538-3540. http://dx.doi.org/10.1128/AAC.02793-13.
12. Boschi L, Mercuri PS, Riccio ML, Amicosante G, Galleni M, Frère J-M, Rossolini GM. 2000. The Legionella (Fluoribacter) gormanii metalloβ lactamase: A new member of the highly divergent lineage of molecularsubclass B3 βlactamases. Antimicrob Agents Chemother 44:1538-1543. http://dx.doi.org/10.1128/AAC.44.6.1538-1543.2000.
13. Queenan AM, Shang W, Flamm R, Bush K. 2010. Hydrolysis and inhibition profiles of -lactamases from molecular classes A to D with doripenem, imipenem, and meropenem. Antimicrob Agents Chemother 54:565-569. http://dx.doi.org/10.1128/AAC.01004-09.
14. Crowder MW, Walsh TR, Banovic L, Pettit M, Spencer J. 1998. Overexpression, purification, and characterization of the cloned metalloβ lactamase L1 from Stenotrophomonas maltophilia. Antimicrob Agents Chemother 42:921-926.
15. Hu H, Hu Y, Pan Y, Liang H, Wang H, Wang X, Hao Q, Yang X, Xiao X, Luan C, Yang Y, Cui Y, Yang R, Gao GF, Song Y, Zhu B. 2012. Novel plasmid and its variant harboring both a bla(NDM-1) gene and type IV secretion system in clinical isolates of Acinetobacter lwoffii. Antimicrob Agents Chemother 56:1698-1702. http://dx.doi.org/10.1128/AAC.06199-11.
16. Makena A, Brem J, Pfeffer I, Geffen RE, Wilkins SE, Tarhonskaya H, Flashman E, Phee LM, Wareham DW, Schofield CJ. 2015. Biochemical characterization of New Delhi metallo-beta-lactamase variants reveals differences in protein stability. J Antimicrob Chemother 70:463-469. http://dx.doi.org/10.1093/jac/dku403.
17. Hornsey M, Phee L, Wareham DW. 2011. A novel variant, NDM-5, of the New Delhi metallo-beta-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob Agents Chemother 55:5952-5954. http://dx.doi.org/10.1128/AAC.05108-11.
18. Tada T, Miyoshi-Akiyama T, Dahal RK, Sah MK, Ohara H, Kirikae T, Pokhrel BM. 2013. NDM-8 metallo-beta-lactamase in a multidrugresistant Escherichia coli strain isolated in Nepal. Antimicrob Agents Chemother 57:2394-2396. http://dx.doi.org/10.1128/AAC.02553-12.
19. Green VL, Verma A, Owens RJ, Phillips SE, Carr SB. 2011. Structure of New Delhi metallo-beta-lactamase 1 (NDM-1). Acta Crystallogr Sect F Struct Biol Cryst Commun 67:1160-1164. http://dx.doi.org/10.1107/S1744309111029654.
20. Zhang H, Hao Q. 2011. Crystal structure of NDM-1 reveals a common beta-lactam hydrolysis mechanism. FASEB J 25:2574-2582. http://dx.doi.org/10.1096/fj.11-184036.